Suchergebnisse - "Lessi, Federica"

PubPharm (55)

1

What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?

enthalten in: Haematologica | 2024

von Autore, F. | Bramanti, S. | Lessi, F. | +18

2

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia : a multicenter real-life experience

enthalten in: Frontiers in oncology | 2024

von Angotzi, F. | Lessi, F. | Leoncin, M. | +8

3

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life" : The SEIFEM Experience

enthalten in: Cancers | 2023

von Fianchi, L. | Guolo, F. | Marchesi, F. | +33

4

Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax

enthalten in: American journal of hematology | 2023

von Candoni, A. | Lazzarotto, D. | Papayannidis, C. | +29

5

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies

enthalten in: Frontiers in oncology | 2023

von Angotzi, F. | Petrella, M. | Berno, T. | +27

6

Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax

enthalten in: American Journal of Hematology | 2023

von Candoni, A. | Lazzarotto, D. | Papayannidis, C. | +29

7

Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia : Results of the GIMEMA AML1516 Protocol

enthalten in: Cancers | 2022

von Messina, M. | Piciocchi, A. | Ottone, T. | +31

8

Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients : Results from SEIFEM 2016-B survey

enthalten in: Mycoses | 2022

von Del Principe, M. | Dragonetti, G. | Conti, A. | +32

9

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia

enthalten in: Clinical case reports | 2022

von Rizzuto, G. | Leoncin, M. | Imbergamo, S. | +13

10

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia

enthalten in: Clinical Case Reports | 2022

von Rizzuto, G. | Leoncin, M. | Imbergamo, S. | +13

1
2
3
4
5
6
Nächster »
[6]